Project Details
| Status | Not started |
|---|
Phase 2, Open-Label Safety and Efficacy Study of Telisotuzumab Vedotin (ABBV-399) in Subjects With Previously Treated c-Met+ Non-Small Cell Lung Cancer
- Zhang, Jun (PI)
- Heyne, Kirk (Key Personnel)
- Singh, Monisha (Key Personnel)
Project: Clinical Trial